Elevance Health, Inc.
ELV
$335.00
-$4.40-1.30%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 42.42B | 41.76B | 41.48B | 36.77B | 37.36B |
| Total Other Revenue | 8.30B | 8.02B | 7.41B | 8.67B | 7.79B |
| Total Revenue | 50.71B | 49.78B | 48.89B | 45.44B | 45.15B |
| Cost of Revenue | 38.14B | 36.71B | 35.31B | 33.50B | 32.95B |
| Gross Profit | 12.57B | 13.07B | 13.58B | 11.94B | 12.20B |
| SG&A Expenses | 10.65B | 10.29B | 10.28B | 10.78B | 9.70B |
| Depreciation & Amortization | 162.00M | 147.00M | 155.00M | 180.00M | 122.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.95B | 47.14B | 45.75B | 44.46B | 42.77B |
| Operating Income | 1.76B | 2.63B | 3.14B | 987.00M | 2.38B |
| Income Before Tax | 1.41B | 2.29B | 2.80B | 606.00M | 1.37B |
| Income Tax Expenses | 219.00M | 548.00M | 613.00M | 193.00M | 365.00M |
| Earnings from Continuing Operations | 1.19B | 1.74B | 2.18B | 413.00M | 1.01B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.00M | -1.00M | -1.00M | 5.00M | 8.00M |
| Net Income | 1.19B | 1.74B | 2.18B | 418.00M | 1.02B |
| EBIT | 1.76B | 2.63B | 3.14B | 987.00M | 2.38B |
| EBITDA | 2.14B | 3.01B | 3.51B | 1.39B | 2.71B |
| EPS Basic | 5.32 | 7.74 | 9.64 | 1.81 | 4.38 |
| Normalized Basic EPS | 3.94 | 6.36 | 7.72 | 1.77 | 5.64 |
| EPS Diluted | 5.32 | 7.72 | 9.61 | 1.81 | 4.36 |
| Normalized Diluted EPS | 3.94 | 6.34 | 7.69 | 1.77 | 5.61 |
| Average Basic Shares Outstanding | 223.30M | 225.20M | 226.40M | 231.10M | 231.90M |
| Average Diluted Shares Outstanding | 223.70M | 225.80M | 227.20M | 231.10M | 233.10M |
| Dividend Per Share | 1.71 | 1.71 | 1.71 | 1.63 | 1.63 |
| Payout Ratio | 32.04% | 22.09% | 17.68% | 89.23% | 37.20% |